Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 337

Neuromelanin-sensitive magnetic resonance imaging (NM-MRI) contrast is associated with psychosis severity in antipsychotic-free patients with schizophrenia, according to a study published online Nov. 8 in JAMA Psychiatry.

Kenneth Wengler, Ph.D., from Columbia University in New York City, and colleagues conducted a cross-sectional study involving 42 antipsychotic-free patients with , 53 antipsychotic-free individuals at clinical high risk for psychosis (CHR), and 52 matched healthy controls to replicate previous findings relating NM-MRI, a proxy measure of dopamine function, to psychosis severity. Data were also included for an external validation sample of 16 antipsychotic-naive patients with schizophrenia.

The researchers found that higher Positive and Negative Syndrome Scale positive total scores correlated with higher mean NM-MRI contrast in the psychosis regions of interest (ROI) in the schizophrenia sample.

Read more | >

Schizophrenia, a neurodevelopmental disorder that features psychosis among its symptoms, is thought to arise from disorganization in brain connectivity and functional integration. Now, a recent study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, finds differences in functional brain connectivity in people with and without psychosis and schizophrenia that could help researchers understand the neural underpinnings of this disease.

The brain’s cortex is organized in a hierarchical fashion, anchored by the sensorimotor cortex at one end and by multimodal association areas at the other, with the task of integrating incoming sensory information with internal and external sensory signals. The loss of executive control in schizophrenia may stem from disruption of this hierarchical signaling.

Alexander Holmes, a Ph.D. candidate at Monash University who led the study, said, “We used brain imaging and novel mathematical techniques to investigate the hierarchical organization of the brains of individuals with early psychosis and established schizophrenia. This organization is important for brain health, as it regulates how we can effectively respond to and process stimuli from the external world.”

Read more | >

Japanese researchers have developed a novel technique to attach engineered skin tissue to humanoid robots.

Robotic platforms may benefit from enhanced mobility, embedded sensing capabilities, self-healing capabilities, and a more realistic appearance.

The innovation was made possible by mimicking skin-ligament structures and using V-shaped perforations in a robot face.

Read more | >

The organoids were treated with zinc oxide nanoparticles (ZnO NPs), which are a liver toxic material, and nontoxic gold nanoparticles (AuNPs). The comparison showed that the toxicity of each material could be accurately observed, in contrast to the conventional method.

Ahruem Baek, a senior researcher at KRISS, said, “Based on our results, we will establish standard nanomaterial and nanomedicine safety assessment procedures using organoids, contributing to the advancement of Korea’s nano-industry.”

The results from this study may allow for rapid and accurate safety assessment of nanomaterials and nanomedicine using organoids, contributing to the safe utilization of nanomaterials in various strategic technical fields.

Read more | >

To help myself and others keep track of the fast-paced world of biotech, I have put together this list of 107 companies and notable research nonprofits! I wrote down some important facts about each entry as well as included links to their websites.

PDF version: List of Biotechnology Companies to Watch – by Logan Thrasher Collins

I created this list of organizations (107 total to date) to serve as a resource to help people learn about and keep track of key biotechnology companies. Some of these are emerging startups, some are established giants, and some provide useful services. Some notable nonprofit organizations are included as well. Though this list is far from comprehensive, I have tried to cover as many of the key players as possible. It is also important to realize that this landscape is constantly changing, so some of the information on this list will eventually transition into antiquity. The list was originally started over the course of 2021, updated during the summer of 2022, and updated again during the summer of 2024. I hope you enjoy delving into the exciting world of biotechnology!

Read more | >